Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
The Journal of Investigative Dermatology
|
July 6, 2023
In Silico and In Vitro Analysis of IL36RN Alterations Reveals Critical Residues for the Function of the Interleukin-36 Receptor Complex
Niina K Hassi, Timir Weston, Giulia Rinaldi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 7, 2023
Comparison of three-weekly and six-weekly pembrolizumab United Kingdom prescribing practice for advanced and resected melanoma
Ishan Mehta, Alimu Dayimu, Satish Kumar, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 29, 2023
A randomised phase 2 study of intermittent versus continuous dosing of dabrafenib plus trametinib in patients with BRAF<sup>V600</sup> mutant advanced melanoma (INTERIM)
Alimu Dayimu, Avinash Gupta, Rubeta N Matin, et al.
The Journal of Investigative Dermatology
|
July 9, 2016
AP1S3 Mutations Cause Skin Autoinflammation by Disrupting Keratinocyte Autophagy and Up-Regulating IL-36 Production
Satveer K Mahil, Sophie Twelves, Katalin Farkas, et al.
The Journal of Allergy and Clinical Immunology
|
July 24, 2018
Clinical and genetic differences between pustular psoriasis subtypes
Sophie Twelves, Alshimaa Mostafa, Nick Dand, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
The Journal of Investigative Dermatology
|
July 6, 2023
In Silico and In Vitro Analysis of IL36RN Alterations Reveals Critical Residues for the Function of the Interleukin-36 Receptor Complex
Niina K Hassi, Timir Weston, Giulia Rinaldi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 7, 2023
Comparison of three-weekly and six-weekly pembrolizumab United Kingdom prescribing practice for advanced and resected melanoma
Ishan Mehta, Alimu Dayimu, Satish Kumar, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 29, 2023
A randomised phase 2 study of intermittent versus continuous dosing of dabrafenib plus trametinib in patients with BRAF<sup>V600</sup> mutant advanced melanoma (INTERIM)
Alimu Dayimu, Avinash Gupta, Rubeta N Matin, et al.
The Journal of Investigative Dermatology
|
July 9, 2016
AP1S3 Mutations Cause Skin Autoinflammation by Disrupting Keratinocyte Autophagy and Up-Regulating IL-36 Production
Satveer K Mahil, Sophie Twelves, Katalin Farkas, et al.
The Journal of Allergy and Clinical Immunology
|
July 24, 2018
Clinical and genetic differences between pustular psoriasis subtypes
Sophie Twelves, Alshimaa Mostafa, Nick Dand, et al.
Page
of 1